US3 plays a role in virus particles egress from the nucleus, in actin cytoskeleton modulation and in apoptosis inhibition
|Product type||Primary antibodies|
|Immunogen||Synthetic peptide derived from an internal domain of Human herpesvirus 1 (strain 17) Serine/threonine-protein kinase US3|
|Activity cross reaction||Reacts with US3 protein from Human herpesvirus 1 (strain 17) (HHV-1). Cross reaction not yet tested.|
|Storage instructions||Lyophilized powder stable for a minimum of 2 years at -20°C.
Store reconstituted antibodies at +4°C.
For extended periods store in aliquots at -20°C.
Antibodies are guaranteed for 6 month from date of receipt.
|Target||Serine/threonine-protein kinase US3<br/>Human herpes simplex virus 1|
|Applications||ELISA, ICC, WB|
|Working dilutions||Optimal dilution should be determined by the end user.
The following are guidelines only :
ICC (1:50 - 1:500)
WB (1:200 - 1:2000)
|Publication||* Santamaría E et al. Identification of replication-competent HSV-1 Cgal+ strain signaling targets in human hepatoma cells by functional organelle proteomics. Mol Cell Proteomics. 2009 Apr:8(4):805-15. (WB)|
Write Your Own Review